Clinical trialNCT00755313CompletedObservational

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

SponsorUniversity of California, San FranciscoEnrollment81Breast CancerChemotherapeutic Agent ToxicityCognitive/Functional EffectsFatigueLong-term Effects Secondary to Cancer Therapy in AdultsNeurotoxicity+1 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Hope S. Rugo, MD
University of California, San Francisco
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Aromatase inhibition therapyCarboplatin →Cyclophosphamide →Docetaxel →Doxorubicin →Trastuzumab →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2007
Primary completion: 30 Sept 2012
Completion: 6 Jun 2014
Last update posted: 24 Nov 2017
Registered enrollment: 81
Registry id: NCT00755313

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.